Successful Multidisciplinary Treatment with Laparoscopic Hepatectomy and Adjuvant Therapy for Metachronous Solitary Hepatic Metastasis after Excision of a Primary Anorectal Malignant Melanoma: A Case Report.
Ryotaro ShimazakiMasahiro HagiwaraChikayoshi TaniHiroyoshi IwataHiroyuki TakahashiMarika FukuyamaTaisuke MatsuyaKoji ImaiSayaka YuzawaMishie TaninoHideki YokooPublished in: Current oncology (Toronto, Ont.) (2023)
Anorectal malignant melanoma (ARMM) is extremely rare and generally lethal, irrespective of the treatment administered. The disease is often diagnosed late, metastases being present in approximately two-thirds of patients at the time of initial diagnosis. Solitary metastasis of ARMM to a distant organ is exceedingly rare. A 76-year-old woman with a history of laparoscopic abdominoperineal resection of an ARMM 13 months previously, was found to have a solitary liver metastasis in the follow-up computed tomography. A preoperative work-up showed no other distant metastases nor contraindication to surgery. It was therefore considered that resection was indicated. The metachronous solitary liver metastasis from an ARMM was treated by laparoscopic wedge hepatectomy of the eighth segment 18 months after excision of her primary ARMM. Adjuvant therapy with pembrolizumab was initiated and continued at 6-week intervals. The patient has not exhibited any immune related Adverse Effects (irAE) during or subsequent to treatment with pembrolizmab and has now completed 12 months of adjuvant pembrolizumab therapy, having survived 33 months from the initial operation for primary ARMM, and remaining recurrence-free 14 months after hepatectomy. ARMM is extremely rare and resection of a metachronous solitary metastasis followed by adjuvant therapy has not previously been reported. We hope this case will be useful for clinicians who might treat similar patients.
Keyphrases
- computed tomography
- robot assisted
- end stage renal disease
- newly diagnosed
- magnetic resonance imaging
- ejection fraction
- rare case
- clinical trial
- chronic kidney disease
- positron emission tomography
- prognostic factors
- early stage
- study protocol
- coronary artery bypass
- case report
- mesenchymal stem cells
- patients undergoing
- rectal cancer
- liver metastases
- peritoneal dialysis
- atrial fibrillation
- cell therapy
- contrast enhanced
- image quality